Researchers reveal why analyses of cancer-causing mutations are riddled with false positives and demonstrate a new approach that eliminates the problem.
The Scientist
Most Recent
Last week’s Supreme Court decision to invalidate patents on human genes was a win for patients, independent researchers, and even the wider biotech industry.
The Justices have decided that isolated sequences of human DNA are not eligible for patent protection, but rules that artificial sequences can be patented.
Support the BRAIN Initiative, but don’t overlook the neurogenomic diagnostics that are already driving breakthroughs in brain and rare neurological disorders.
Researchers identify thousands of plant genes activated by the gaseous hormone ethylene, which influences ripening, pathogen defense, growth regulation, and more.
A new analysis suggests that the Human Genome Project has delivered $178 for every federal dollar invested, but many analysts are not convinced by the figures.
Researchers identify the signaling program that enables finger and toenail stem cells to direct digit regeneration after amputation.
Leading medical and research centers around the world announce a plan to share massive amounts of genetic and clinical information.
A compound that targets a particular opioid receptor in the amygdala reduces the formation of PTSD-like systems in mice subjected to severe trauma.
In avian species, a gene induces programmed cell death during development in the area where a phallus would otherwise grow.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
